Asad Ikram: Headache and Visual Impairment in Idiopathic Intracranial Hypertension
Asad Ikram, Assistant Professor of Medicine at Anne Burnett Marion School of Medicine at Texas Christian University, shared a post on LinkedIn about a recent article by Gabriel Bsteh et al, published on European Journal of Neurology, adding:
“Headache and Visual Impairment in idiopathic intracranial hypertension (IIH)
The role of surgical interventions in IIH related headache vs visual impairment and what those offer: a very pragmatic look at when and in whom procedures actually help.
Across multiple tertiary centers, investigators evaluated outcomes of patients undergoing CSF shunting, venous sinus stenting, or optic nerve sheath fenestration (ONSF), with a focus on how indication for surgery (vision vs headache) influences results.
What stands out is that surgery is consistently effective for vision preservation, with most patients showing stabilization or improvement in visual function after intervention.
However, outcomes for headache control were far less predictable, with a significant proportion continuing to have persistent or recurrent symptoms despite technically successful procedures.
Complication and revision rates particularly for shunts were not negligible, reinforcing the need for careful patient selection.
From a neurovascular and stroke-adjacent perspective, this is highly relevant because we often encounter IIH in young patients presenting with headache or visual symptoms, sometimes mimicking vascular pathology and often associated with Dural Venous Sinus thrombosis needing anticoagulation.
The key takeaway is that surgical intervention should be driven primarily by visual risk rather than headache alone, and that multidisciplinary evaluation (neurology, neuro-ophthalmology, neurosurgery) is critical before committing patients to invasive therapies.”
Title: Surgical Interventions in Idiopathic Intracranial Hypertension—A Comprehensive Multi‐Center Study of Outcome and the Role of Treatment Indication
Authors: Gabriel Bsteh, Nadja Skadkær Hansen, Sina Zaic, Steffen Hamann, Johanne Juhl Korsbæk, Nik Krajnc, Stefan Macher, Laleh Dehghani Molander, Klaus Novak, Therese Wallentin Steenfos, Marianne Wegener, Berthold Pemp, Rigmor Højland Jensen, Dagmar Beier, Kaare Fugleholm, Marianne Juhler, Karl Kirchner, Martin Michl, Christoph Mitsch, Nina Müller, Petersen Bibi Gronemann, Andreas Reitner, Christoph Stapf, Christian Wöber, Karin Zebenholzer
Read the Full Article on European Journal of Neurology
Stay updated with Hemostasis Today.
-
Mar 28, 2026, 19:04Roberta Gualtierotti: High Engagement for Research on Non-Replacement Therapies in Hemophilia
-
Mar 28, 2026, 19:02Marking a Century of Progress in von Willebrand Disease – HFA
-
Mar 28, 2026, 18:57Jim Hoffman: NETosis Dysregulation Links Cancer Progression and Autoimmunity
-
Mar 28, 2026, 18:55Ifeanyichukwu Ifechidere: Which Coagulation Factors Are Not Involved in Bleeding?
-
Mar 28, 2026, 18:54Examining Critical Gaps in AF Stroke Prevention – JTH
-
Mar 28, 2026, 18:52Simon Senanu: Key Laboratory Markers of Hemolytic Anemia
-
Mar 28, 2026, 18:48Abdul Mannan: How SSRIs Might Affect Platelet Function
-
Mar 28, 2026, 18:47Cedric Hermans: A Useful Platform for Daily Practice in Hemostasis
-
Mar 28, 2026, 18:41Amy Delderfield: One Trial, Big Implications for Anticoagulant Choice